De beoordeling van nieuwe geneesmiddelen. Article in Pharmaceutisch weekblad 3(1) Henk Buurma at Independent Researcher. Henk Buurma. Buy Het juiste medicijn: ruim geneesmiddelen kritisch beoordeeld 01 by Marcel Bouvy, Henk Buurma (ISBN: ) from Amazon’s Book Store. Buurma, H., Jong-van den Berg, L.T.W. de, Leufkens, H.G.M., Het geneesmiddel, Wetenschappelijke uitgeverij Bunge, Utrecht Callon, M, Law, J., Rip, A.
|Published (Last):||6 June 2013|
|PDF File Size:||8.52 Mb|
|ePub File Size:||10.23 Mb|
|Price:||Free* [*Free Regsitration Required]|
Skip to Content Skip to navigation. Prescribing quality and indicators. Shared decision making and decision support tools. University of Groningen staff: About us How to find us prof. Faculty of Medical Sciences. A systematic review of measures estimates adherence and persistence to multiple medications Alfian, S.
Journal of Geneesmixdel Epidemiology. Gender differences in adverse drug reaction buurm How can they be explained? Is guideline-adherent prescribing associated jet quality of life in patients with type 2 diabetes?
Efficient selection of older patients for medication review: Pharmacoepidemiology and Drug Safety. Gender differences in drug-Adverse drug reaction combinations reported to the national pharmacovigilance centre in the Netherlands de Vries, S. HbA1c response after insulin initiation in patients with type 2 diabetes mellitus in real life practice: Identifying distinct subgroups Sidorenkov, G.
Non-LDL dyslipidemia is prevalent in the young and determined by lifestyle factors and age: The LifeLines cohort de Vries, J. Individual variability in response to renin angiotensin aldosterone system inhibition predicts cardiovascular outcome in patients with type 2 diabetes: A primary care cohort study Apperloo, E. Added value of diabetes risk genes to the prediction of HbA1c levels in patients initiating metformine or sulfonylurea derivatives.: Naunyn-Schmiedebergs Archives of Pharmacology.
Views of general practice staff about the use of a patient-oriented treatment decision aid in shared decision making for patients with type 2 diabetes: A mixed-methods study Wildeboer, A.
Diabetes mellitus type 2: Apotheker wordt beter zichtbaar voor medicijngebruiker Crutzen, S. Pharmacy-based predictors of non-persistence with and non-adherence to statin treatment among patients on oral diabetes medication in the Netherlands Alfian, S. Current Medical Research and Opinion. Long-term exposure to anticholinergic and sedative drugs and cognitive and physical function in later life Wouters, H.
Trajectories of long-term exposure to anticholinergic and sedative drugs: A latent class growth analysis Wouters, H. Predictors of non-adherence to and non-persistence with statin therapy among patients on oral diabetes medication in the netherlands: A retrospective inception cohort study Alfian, S.
Communication on Safety of Medicines in Europe: Patient attitudes towards deprescribing of alpha-blockers and willingness to participate in a discontinuation trial Edelman, M. Outcome prioritisation tool for medication review in older patients with multimorbidity: British Journal of General Practice. Development and validation of prescribing quality indicators for patients with type 2 diabetes Smits, K.
International Journal of Clinical Practice. Predictors of HbA1c levels in patients initiating metformin Martono, D. Journal of bioethical inquiry. Development and initial validation of prescribing quality indicators for patients with chronic kidney disease Smits, K. Process quality indicators for chronic kidney disease risk management: Prescribing patterns, adherence and LDL-cholesterol response of type 2 diabetes patients initiating statin on low-dose versus standard-dose treatment: Identification of major cardiovascular events in patients with diabetes using primary care data Pouwels, K.
Adherence to standard-dose or low-dose statin treatment and low-density lipoprotein cholesterol response in type 2 diabetes patients de Vries, F. Predictors of response in initial users of metformin and sulphonylurea derivatives: Understanding drug preferences, different perspectives Mol, P. British Journal of Clinical Pharmacology. Does a cardiovascular event change adherence to statin treatment in patients with type 2 diabetes? A matched cohort design de Vries, F.
Efficacy of standard and intensive statin treatment for the secondary prevention of cardiovascular and cerebrovascular events in diabetes patients: A meta-analysis De Vries, F.
The validity of a patient-reported adverse drug event questionnaire using different recall periods de Vries, S. Quality of Life Research. A matched cohort design De Vries, D.
prof. dr. P. (Petra) Denig
Effects of a patient oriented decision aid for prioritising treatment goals in diabetes: BMJ Clinical research ed. Construct and concurrent validity of a patient-reported adverse drug event questionnaire: New renal guidelines; is more better? Cost-effectiveness of statins for primary prevention in patients newly diagnosed with type 2 diabetes in the Netherlands de Vries, F.
Medication beliefs, treatment complexity, and non-adherence to different drug classes in patients with type 2 diabetes de Vries, S. Journal of Psychosomatic Research. Effects of the occurrence of a first cardiovascular event on statin adherence in type 2 diabetes: A matched cohort design De Vries, F. Cost-effectiveness of statins for primary prevention in newly diagnosed type 2 diabetes patients: Treatment quality indicators predict short-term outcomes in patients with diabetes: Is albuminuria screening and treatment optimal in patients with type 2 diabetes in primary care?
Representativeness of diabetes patients participating in a web-based adverse drug reaction monitoring system Harmark, L. Pharmcoepidemiology and Drug Safety. The effect of a patient-oriented treatment decision aid for risk factor management in patients with diabetes PORTDA-diab: Development of a minimal set of prescribing quality indicators for diabetes management on a general practice level Martirosyan, L. A pilot qualitative study to explore stakeholder opinions regarding prescribing quality indicators Martirosyan, L.
Differential effects of comorbidity on antihypertensive and glucose-regulating treatment in diabetes mellitus: Coping with adverse drug events in patients with heart failure: Exploring the role of medication beliefs and perceptions De Smedt, R. Primary prevention of major cardiovascular and cerebrovascular events with statins in diabetic patients: Self-reported adverse drug events and the role of illness perception and medication beliefs in ambulatory heart failure patients: A cross-sectional survey De Smedt, R.
International Journal of Nursing Studies. A review of methods used in assessing non-serious adverse drug events in observational studies among type 2 diabetes mellitus patients Hakobyan, L.
A longitudinal study examining adherence to guidelines in diabetes care according to different definitions of adequacy and timeliness Sidorenkov, G. Medical Care Research and Review. Do we need individualised prescribing quality assessment? The case of diabetes treatment Denig, P. International Journal of Clinical Pharmacy.
Petra Denig – Research database – University of Groningen
Cardiometabolic treatment decisions in patients with type 2 diabetes: Methods to identify the target population: A systematic literature review: Kwaliteit van de behandeling van type 2-diabetes: Nederlands Tijdschrift voor Geneeskunde. Reasons of bjurma practitioners for not prescribing lipid-lowering medication to patients with diabetes: Comparison of various measures for assessing medication refill adherence using prescription data Vink, N.
Perceived medication adverse effects and coping strategies reported by chronic heart failure patients De Smedt, R. Voorschrijven van geneesmiddelen Denig, P. Elsevier Gezondheidszorgp.
Prescribing quality indicators nuurma type 2 diabetes mellitus ambulatory care Martirosyan, L. Influence of elevated cardiometabolic risk factor levels on treatment changes in type 2 diabetes Voorham, J. Cross-sectional versus sequential quality indicators of risk factor management in patients with type 2 diabetes Voorham, J. Trends in hyperlipidemia and hypertension management in type 2 diabetes patients from buumra